venBio Global Strategic GP II, Ltd., 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), sold 1,033,268 shares at $10.39 ($10.8M) on 2022-04-20, disclosed to the SEC on 2022-04-21.
Open-market sale of $10.8M CMPI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.42 | 399,923 | $4.2M | 38.7% |
| 2 | $10.42 | 399,923 | $4.2M | 38.7% |
| 3 | $10.39 | 85,611 | $889K | 8.3% |
| 4 | $10.39 | 85,611 | $889K | 8.3% |
| 5 | $10.38 | 62,200 | $646K | 6.0% |
| Total | $10.41 avg | 1,033,268 |
| $10.8M |
| 100% |
| Filing → |
| AKRO | BUY | 2019-06-25 | $4.0M | — | Filing → |